FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Hollis-Eden Pharmaceuticals related Press Releases

Hollis-Eden Pharmaceuticals Presents Additional Positive Findings for APOPTONETM (HE3235) in Preclinical Models of Castration-Re

Posted September 29, 2008

Hollis-Eden Pharmaceuticals Presents Additional Positive Findings for APOPTONETM (HE3235) in Preclinical Models of Castration-Resistant Prostate Cancer September 29, 2008 SAN DIEGO--(BUSINESS Read more...

PRESS RELEASE: Hollis-Eden Pharmaceuticals Presents Positive Results with Novel Drug Candidate HE3235

Posted October 4, 2007

Hollis-Eden Pharmaceuticals Presents Positive Results with Novel Drug Candidate HE3235 in Model of Hormone Independent Prostate Cancer SAN DIEGO -- Oct 4, 2007 - Hollis-Eden Pharmaceuticals the Read more...

PRESS RELEASE: Hollis-Eden Pharmaceuticals Presents HE3235 Update at ASCO Breast Cancer Symposium

Posted September 7, 2007

Hollis-Eden Pharmaceuticals Presents HE3235 Update at ASCO Breast Cancer Symposium Preclinical Data Show Lasting Anti-Tumor Effect of Novel Drug Candidate SAN DIEGO -- Hollis-Eden Pharmaceuticals, Read more...